Tag: Dana-Farber Cancer Institute

Matthew H. Kulke MD May27

Dr. Matthew H. Kulke to be Featured Guest for CCF’s Luncheon with the Experts

May 23, 2021

Matthew H. Kulke, MD, medical oncologist and hematologist, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, May 27 from 12 noon to 1 pm, Eastern Time. Dr. Kulke is the Chief of Hematology/Oncology, Co-Director …

READ MORE
jennifer chan md and matthew kulke md

Neuroendocrine Tumors Focus of Upcoming Issue of Hematology/Oncology Clinics

November 27, 2015

Neuroendocrine Tumors will be featured in the February 2016 issue of Hematology/Oncology Clinics. Dr. Jennifer Chan and Dr. Matthew Kulke, both from Dana-Farber Cancer Institute in Boston, Massachusetts are Editors of the issue, published by Elsevier.…

READ MORE
carcinoid syndrome lexicon pharmaceuticals telotristat etiprate clinical trial

Lexicon’s Carcinoid Syndrome Treatment Meets Primary Endpoint in Phase III Clinical Trial

August 5, 2015

Lexicon Pharmaceuticals Inc. has announced that the pivotal phase III clinical trial, TELESTAR, of its oral drug candidate telotristat etiprate met the primary endpoint in treating cancer patients with carcinoid syndrome that is not adequately controlled…

READ MORE
sticky example

10 Highlights for the Carcinoid and Neuroendocrine Tumor Community

June 12, 2015
  • PET/CT using Gallium-68 DOTATOC captures hidden source of neuroendocrine cancer. “An investigational molecular imaging technique could be the key to finding the elusive primary tumor, say presenters at the 2015 Annual Meeting of the Society
READ MORE
plk1 pdb 1q4k

Clinical Trial for GI Carcinoid Patients Recruiting Through September

July 23, 2014

Gastrointestinal carcinoid patients who have tumors that either are not suitable for standard treatment or are not responding to standard treatment have the opportunity to enroll in a Phase I/II clinical trial conducted by Tekmira Pharmaceuticals

READ MORE
jennifer chan md 2

New England Carcinoid Connection Announces June 2014 Conference for the Carcinoid and Neuroendocrine Tumor Community

April 29, 2014

Carcinoid and neuroendocrine cancer patients, family members, caregivers, and healthcare professionals are invited to attend the New England Carcinoid Connection Conference on Friday, June 27, 2014 at The Lantana in Randolph, Massachusetts. The…

READ MORE
matthew kulke onctv biomarkers

OncLive TV Releases 2 More Videos in Neuroendocrine Tumors Series

April 1, 2013

Two new videos have been released in the OncLive TV series on carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors, and genetic syndromes that predispose people to develop pancreatic NETs such MEN1 (multiple endocrine…

READ MORE
matthew kulke md

New OncLive TV Series Focuses on Neuroendocrine Tumors

March 24, 2013

Carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors and even more uncommon NETs such as goblet cell carcinoid and mixed adenocarcinomas, are discussed by a panel of medical experts in this new video series from …

READ MORE
thomas e clancy md

New England Carcinoid Connection (NECC) Announces June 2012 Conference

March 30, 2012

Carcinoid and neuroendocrine cancer patients, family members, caregivers, and healthcare professionals are invited to attend the New England Carcinoid Connection Conference on Friday, June 8, 2012 at The Lantana in Randolph, Massachusetts. The…

READ MORE
healthy body healthy mind

Neuroendocrine Tumors Featured on Healthy Body, Healthy Mind Television Series

February 11, 2011

For a comprehensive overview of neuroendocrine tumors, watch this fascinating video on the Healthy Body, Healthy Mind television series. Every episode on the health and wellness TV series focuses on the stories of real people; people who are working…

READ MORE